Background: early detection and diagnosis of hepatic focal lesions are an important step in clinical work, which would allow effective surgical or mini-invasive therapy. With the advances in magnetic resonance imaging (MR) technology, diffusion-weighted magnetic resonance imaging (DWI) is now widely used as a standard imaging sequence in clinical work and shows its potential benefit in evaluation of the focal hepatic lesions. Aim of the work: the use of MR Diffusion imaging with both low and high B values to detect and differentiate between benign and malignant hepatic focal lesion. Methodology: the present study included 30 patients. They were El-Demerdash hospital patients with hepatic focal lesions. Patients underwent US or CT before MR examination. Results: thirty patients were included in this study, 20 males and 10 females. The patient's age was ranging from 33 to 60 years. There were 24 primary hepatic focal lesions, (36.7% HCC, 3.3% focal nodular hyperplasia, 3.3% cysts, 13.3% hemangiomas, 6.7% cholangiocarcinoma, 16.7% regeneration nodule) and 6 metastatic lesions. Conclusion: we hope to use DWI to be helpful in the characterization of focal liver lesions, especially if the lesions show non classic appearance of contrast enhancement in Triphasic CT study and in patients with renal insufficiency with inability to use contrast enhancement. Recommendations: in our opinion, DWI is a useful adjunct to routine liver imaging (i.e. used as an additional sequence to the standard protocol study and not as a unique imaging series); it is fast, requires no intravenous contrast and is non-invasive. The radiologist has to be aware of the potential pitfalls and limitations of the technique. In patients who cannot receive gadolinium-based contrast agents, DW MR imaging has the potential to be a reasonable alternative technique to contrast-enhanced imaging. We suggest the following strategy for evaluating DWI features of FLLs. We believe that most of the FLLs can be practically classified as benign or malignant by using this scheme.
INTRODUCTION
Early detection and diagnosis of hepatic focal lesions are an important step in clinical work, which would allow effective surgical or mini-invasive therapy (1, 2) . With the advances in magnetic resonance imaging (MR) technology, diffusionweighted magnetic resonance imaging (DWI) is now widely used as a standard imaging sequence in clinical work and shows its potential benefit in evaluation of the focal hepatic lesions (3, 4) . DWI with low value can suppress the intra hepatic vascular signal, creating the socalled black blood effect, which improves the detection of small focal liver lesions (FLLs) especially localized near small hepatic vessels. Meanwhile, DWI with low-value has higher imaging quality compared with single shot fast spin-echo sequences (5, 6) . A substantial number of studies have compared low B-value DWI with T2-weighted imaging (T2WI) for image quality and detection of FLLs. These studies generally showed better performance of DWI with lowvalue in terms of lesion detection compared with T2WI (2) . DWI with higher b-value mainly reflects diffusion information of water molecules motion within the lesions, which help to improve the characterization of solid FLLs (4) . Meanwhile, we found in practice that DWI with higher b -value also enables a better detection of lesions in liver compared with T2WI or other conventional sequences. For example, solid focal liver lesions such as focal nodular hyperplasia and hepato cellular carcinomas (HCCs) sometime can be difficult to be detected on T2WI or even DWI with low b -value due to either iso-or slightly hyper signal intensity to liver parenchyma (7, 8) . Diffusion is a physical process that results from the thermally driven, random motion of water molecules. In a container of 1177 water, molecules undergo free, thermally agitated diffusion (with a three dimensional Gaussian distribution) (6) . The b-value represents the diffusion factor (measured in s/mm 2 ) and the strength of the diffusion gradients. The ideal b-value for lesion characterization is a trade-off between signal attenuation and perfusion contamination. This is generally possible using b-values between 400 and 1000 s/mm 2 for liver imaging. Pure diffusion contrast is obtained when using b-values above 1000 s/mm 2 . However, image quality can be limited by signal loss that occurs at such high b-values (9) . Two independent observers reviewed DW (b values of 0, 500, and 1000 sec/mm 2 ) and T2-weighted images for FLL detection and characterization. Reference standard for diagnosis was obtained from consensus review by the two observers of DW, T2-weighted, pathological data, and follow-up imaging results. Apparent diffusion coefficient (ADC) was measured for FLLs identified at consensus review. DW and T2-weighted images were compared for FLL detection and characterization by using a binary logistic regression model. Receiver operating characteristic curve analyses was conducted to evaluate the utility of ADC for diagnosis of malignancy (9) .
Aim of the Work
The use of MR Diffusion imaging with both low and high B values to detect and differentiate between benign and malignant hepatic focal lesion.
PATIENT AND METHODS Study Population:
This study included 30 patients. 
B. Diffusion study:
Respiratory-triggered fat-suppressed single-shot echoplanar DW imaging was perform in the transverse plane with tridirectional diffusion gradients by using b values (0, 500&1000) sec/mm 2 to increase sensitivity to cellular packing. Parallel imaging with generalized auto-calibrating partially parallel acquisition (GRAPPA) with an acceleration factor of two was apply to improve image quality. The other parameters were as follows: repetition time (TR) ≥1880 msec, echo time (TE) = 70 msec, number of excitations (NEX)=3, matrix 256x256, slice thickness 7-8mm, slice gap 1-2mm, scan time 3-4minwith a field of view as small as possible with 52% rectangular field of view.
Imaging Evaluation
The morphological features of each lesion were recorded included size, shape, 1178 margin and signal characteristics, as well as number and site of the detected focal lesions. Then, provisional diagnosis was report. Second, we reviewed the diffusion images with ADC values for final radiological detection and characterization of focal lesions.
ADC Calculation
The mean ADC of each detected focal lesion is measured by drawing a region of interest (ROI) over the lesion. The ADC was measure twice and the two measurements were averaged. To ensure that the same areas were measured, regions of interest were copied and pasted from DWMRI.
The study was done after approval of ethical board of Ain Shams university and an informed written consent was taken from each participant in the study. 
Statistical methods

RESULT
Thirty patients were included in this study, 20 males and 10 females. There were 24 primary hepatic focal lesions, (36.7% HCC, 3.3% focal nodular hyperplasia, 3.3% cysts, 13.3% hemangiomas, 6.7% cholangiocarcinoma, 16.7% regeneration nodule) and 6 metastatic lesions. All cystic lesions showed facilitated diffusion, where they showed reduction of signal intensity on increasing the b-values, and those which didn't show reduction of signal showed high signal on ADC map, which also reflects facilitated diffusion. On the other hand all solid lesions showed restricted diffusion evidenced by increased signal on increasing the b-values and low signal on ADC maps. 
DISCUSSION
Correct detection, classification, and characterization of hepatic focal lesions are of paramount importance as they may significantly affect the choice of therapeutic approach in many cases (10) . The liver is an organ in which various benign or malignant, primary or secondary masses can be detected. Today, focal masses are diagnosed using ultrasonography and/or computed tomography. Additionally, magnetic resonance imaging is preferred when further characterization of these masses is needed. MRI has many advantages (e.g., high contrast resolution, the ability to obtain images in any plane, lack of ionizing radiation, and the safety of using particulate contrast media rather than those containing iodine) that make it a favored modality (11) . Although dynamic contrast enhanced MR examinations have become a routine component of abdominal imaging, the high cost/benefit ratio and risk of contrast media side effects remain an issue (12) . DW-MRI provides unique insight into tissue cellularity, tissue organization, integrity of cells and membranes, as well as the tortuosity of the extracellular space, which can be helpful for detecting malignant diseases, and for distinguishing tumour tissues from non-tumour tissues (13) . Muller et al. first reported in 1994 on diffusion-weighted MRI of normal hepatic, splenic, and muscular tissues, as well as on focal and diffuse hepatic diseases, and obtained significant results. In the years that followed, several studies on liver, kidney, and other abdominal organs examined with diffusion weighted MRI were published. In these studies it was shown that apparent diffusion coefficient values of normal tissues and lesions can be measured using diffusionweighted images, and the differences in ADC values can be used in the differential diagnosis (11) .
The major aim of the present study was to determine the usefulness of diffusion weighted behavior in the various focal lesions of the liver, using ADC measurement, and to determine its contribution to differential diagnosis.
The current study was conducted including thirty patients 20 males and 10 females, with age ranging from 33-60 years.
In our study three different b values were conducted which was in line with the study performed by Parikh et al. (9) and Qayyum et al. (14) although the later stated that the use of only two b values (one of which is low and the other is high) can lead to ADC calculation (at least two values).
As well as the disadvantage of using multiple b values is an associated increase in scanning time which was mentioned by Bachir and Dow (15) . This study was conducted with high b value (500&1000 sec/mm 2 ) to overcome the effect of capillary perfusion and water diffusion in extracellular extravascular space, as high b value will result in the reduction of signal from moving protons in the bile ducts, cysts, vessels, and fluid in the bowel. This will result in an increased contrast between the lesion and liver. Furthermore, the differences in the relative contrast ratio between malignant and benign lesions were increased with a high b value. This was similar to the b value used in other studies (11, 12) . In our study, small lesions were effectively detected on diffusion weighted images, where lesions as small as 0.5cm were clearly depicted, thus making DW MRI a useful tool for detection of small focal hepatic lesions even without contrast injection.
In the current study cysts and hemangiomas showed facilitated diffusion whereas solid tumoral lesions showed restricted diffusion. This data is similar to that present in literature (16) , which stated that cellular tissues, such as tumors, demonstrates restricted diffusion (high signal intensity) on higher b value (500 sec/mm 2 ) images and by contrast, cysts and hemangiomas show a greater degree of signal attenuation on higher b value diffusion images.
As a general observation, both benign and malignant solid lesions may demonstrate residual high signal intensity on higher b value images and this makes it difficult to depend only on inspecting and reviewing the images to characterize the lesion's nature. This was also stated by Taouli and Koh (16) and Parikh et al. (9) that it would be difficult to characterize focal lesions with visual assessment of the DW MR images alone. Hence, once a cellular hepatic lesion is identified visually, further characterization usually relies on conventional morphologic imaging, supplemented with ADC measurements.
And since visual interpretation of images and characterization of lesions depending on diffusion appearance of lesions has its limitation, therefore the calculation of the ADC values was of importance in lesions assessment.
The absolute ADC values of the different types of lesions were not similar, which is probably due to differences in techniques applied (b value, breath measurement methods, and mathematical technique applied). This finding was also stated by Petra and Eric (17) were they stated that in spite there are an increasing number of studies dealing with quantitative measurements of ADC in liver lesions, there are many discrepancies in the reported ADC values where there is no cut-off value for ADC values in normal parenchyma, benign and malignant lesions and this is often associated with many technical parameters such as the use of respiratory-triggered versus breath-hold diffusion-weighted protocol and significantly b value as high b value results in low ADC value and vice versa. Yet our findings were similar to previous studies in many aspects as follows:
The ADC measurements of benign and malignant hepatic masses were significantly different with a p value >0.0001, which supports similar previous findings where Onura MR et al. (18) stated that the mean ADC values of benign lesions were higher than malignant lesions. Miller et al. (19) stated that the ADC values of benign hepatic lesions were significantly higher than that of malignant hepatic tumors, with a P value < 0.05.
Vergara et al. (20) stated that the mean ADC value obtained for benign lesions differed significantly from the average for malignant lesions with a p value <0.05 Demir et al. (11) Stated that the difference between the mean ADC values of benign and malignant lesions was statistically significant (P < 0.01).
The lowest ADC values belonged to metastases with ADC value of 1.04x10
Robert et al. (21) reported that regenerative nodules demonstrate variable signal on T1-weighted images. On T2-weighted MR imaging, typical regenerative nodules are isointense to hypointense, but they are almost never hyperintense on T2-weighted imaging. In our study, the regenerative nodules were hyperintense on T1 WIs. On T2 WIs and SPAIR sequences, the regenerative nodules were hypointense, show free facilitated diffusion on DWIs with high ADC value. In dynamic MR study, all regenerative nodules were isointense to the liver parenchyma.
STUDY LIMITATIONS
Was the low number of lesions, especially the benign solid hepatocellular lesions (e.g., hepatic adenoma), thus making the comparison between solid benign and malignant masses limited.
CONCLUSION
We hope to use DWI to be helpful in the characterization of focal liver lesions, especially if the lesions show non classic appearance of contrast enhancement in Triphasic CT study and in patients with renal insufficiency with inability to use contrast enhancement.
RECOMMENDATIONS
In our opinion, DWI is a useful adjunct to routine liver imaging (i.e. used as an additional sequence to the standard protocol study and not as a unique imaging series); it is fast, requires no intravenous contrast and is non-invasive. The radiologist has to be aware of the potential pitfalls and limitations of the technique. In patients who cannot receive gadolinium-based contrast agents, DW MR imaging has the potential to be a reasonable alternative technique to contrast-enhanced imaging. We suggest the following strategy for evaluating DWI features of FLLs. We believe that most of the FLLs can be practically classified as benign or malignant by using this scheme.
